| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 20.9K | 30 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 17:34 |
| ATHA | Athira Pharma, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 19:00 |
| ATHA | Athira Pharma, Inc. | 19 May 2023 | 1 | $0 | 4 | Director | 22 May 2023, 18:08 |
| ATHA | Athira Pharma, Inc. | 29 Mar 2023 | 1 | $12K | 4 | Director | 30 Mar 2023, 18:59 |
| ATHA | Athira Pharma, Inc. | 20 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 17:40 |
| ATHA | Athira Pharma, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 18:11 |